{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:45:39Z","timestamp":1772171139305,"version":"3.50.1"},"reference-count":130,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T00:00:00Z","timestamp":1286409600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000955","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T16:04:20Z","timestamp":1286467460000},"page":"e1000955","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies"],"prefix":"10.1371","volume":"6","author":[{"given":"S.","family":"Gnanakaran","sequence":"first","affiliation":[]},{"given":"Marcus G.","family":"Daniels","sequence":"additional","affiliation":[]},{"given":"Tanmoy","family":"Bhattacharya","sequence":"additional","affiliation":[]},{"given":"Alan S.","family":"Lapedes","sequence":"additional","affiliation":[]},{"given":"Anurag","family":"Sethi","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[]},{"given":"Haili","family":"Tang","sequence":"additional","affiliation":[]},{"given":"Kelli","family":"Greene","sequence":"additional","affiliation":[]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[]},{"given":"Myron S.","family":"Cohen","sequence":"additional","affiliation":[]},{"given":"George M.","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[]},{"given":"Bette","family":"Korber","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2010,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ni0304-233","article-title":"HIV vaccine design and the neutralizing antibody problem.","volume":"5","author":"DR Burton","year":"2004","journal-title":"Nat Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/14760584.5.4.579","article-title":"Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.","volume":"5","author":"BF Haynes","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1566524033479799","article-title":"Defining the protective antibody response for HIV-1.","volume":"3","author":"JR Mascola","year":"2003","journal-title":"Curr Mol Med"},{"key":"ref4","article-title":"The role of antibodies in HIV vaccines.","author":"JR Mascola","year":"2009","journal-title":"Ann Rev Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jama.1994.03520060075035","article-title":"Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1.","volume":"272","author":"RB Belshe","year":"1994","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/088922200750054756","article-title":"Immunization with recombinant canarypox vectors expressing membrane-anchored gp120 followed by gp160 protein boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.","volume":"16","author":"R Bures","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/173.2.340","article-title":"Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory adapted but not primary isolates of human immunodeficiency virus type 1.","volume":"173","author":"JR Mascola","year":"1996","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.","volume":"191","author":"NM Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/428405","article-title":"Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.","volume":"191","author":"PB Gilbert","year":"2005","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/422258","article-title":"Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.","volume":"190","author":"S Nitayaphan","year":"2004","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines.","volume":"2","author":"DR Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tibtech.2008.08.002","article-title":"Structure-based antigen design: a strategy for next generation vaccines.","volume":"26","author":"PR Dormitzer","year":"2008","journal-title":"Trends Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/138161207779313632","article-title":"Rational modifications of HIV-1 envelope glycoproteins for immunogen design.","volume":"13","author":"S Phogat","year":"2007","journal-title":"Curr Pharm Des"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/COH.0b013e32832e6184","article-title":"Challenges for structure-based HIV vaccine design.","volume":"4","author":"WR Schief","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1128\/JVI.76.15.7863-7867.2002","article-title":"Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.","volume":"76","author":"RJ Center","year":"2002","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition.","volume":"93","author":"DC Chan","year":"1998","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.","volume":"280","author":"R Wyatt","year":"1998","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/096876899294706","article-title":"Structural basis for membrane fusion by enveloped viruses.","volume":"16","author":"W Weissenhorn","year":"1999","journal-title":"Mol Membr Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor binding sites.","volume":"420","author":"PD Kwong","year":"2002","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/JVI.00093-06","article-title":"Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.","volume":"80","author":"SG Deeks","year":"2006","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20052116","article-title":"Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus.","volume":"203","author":"R Draenert","year":"2006","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.0505126102","article-title":"Antibody vs HIV in a clash of evolutionary titans.","volume":"102","author":"DR Burton","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/JVI.02500-06","article-title":"Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity.","volume":"81","author":"B Dey","year":"2007","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1000445","DOI":"10.1371\/journal.ppat.1000445","article-title":"Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site.","volume":"5","author":"B Dey","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1128\/JVI.02600-08","article-title":"Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.","volume":"83","author":"L Wu","year":"2009","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.vaccine.2004.09.037","article-title":"Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing responses.","volume":"23","author":"J Ho","year":"2005","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45811","DOI":"10.1074\/jbc.M205862200","article-title":"Enhancement of \u03b1-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing antibody responses in vitro.","volume":"277","author":"JG Joyce","year":"2002","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1016\/j.vaccine.2006.09.071","article-title":"Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.","volume":"25","author":"M Kim","year":"2007","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.","volume":"22","author":"RM Cardoso","year":"2005","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.","volume":"78","author":"G Ofek","year":"2004","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1061692","article-title":"Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design.","volume":"293","author":"EO Saphire","year":"2001","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.str.2004.01.003","article-title":"Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.","volume":"12","author":"RL Stanfield","year":"2004","journal-title":"Structure (Camb)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120.","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1128\/JVI.79.14.8812-8827.2005","article-title":"Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.","volume":"79","author":"S Beddows","year":"2005","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2004.09.022","article-title":"Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.","volume":"331","author":"C Grunder","year":"2005","journal-title":"Virology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.vaccine.2009.06.037","article-title":"Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.","volume":"27","author":"Y Kang","year":"2009","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.virol.2006.04.043","article-title":"A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C primary viruses.","volume":"353","author":"H-X Liao","year":"2006","journal-title":"Virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1128\/JVI.01762-08","article-title":"Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.","volume":"82","author":"JM Binley","year":"2008","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02749-06","article-title":"Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.","volume":"81","author":"AK Dhillon","year":"2007","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nm1624","article-title":"Broad HIV-1 neutralization mediated by CD4-binding site antibodies.","volume":"13","author":"Y Li","year":"2007","journal-title":"Nat Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JVI.02036-08","article-title":"Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.","volume":"83","author":"DN Sather","year":"2009","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.","volume":"308","author":"BF Haynes","year":"2005","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/HAB-2005-143-402","article-title":"Antibody polyspecificity and neutralization of HIV-1: a hypothesis.","volume":"14","author":"BF Haynes","year":"2005","journal-title":"Hum Antibodies"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2006-08-038661","article-title":"Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses.","volume":"109","author":"K Fernando","year":"2007","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.176.7.3931","article-title":"HIV-1 envelope triggers polyclonal IgG class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.","volume":"176","author":"B He","year":"2006","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1371\/journal.ppat.0030169","article-title":"HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.","volume":"3","author":"M Shan","year":"2007","journal-title":"PLoS Path"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.","volume":"78","author":"JM Binley","year":"2005","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal new HIV-1 vaccine target.","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?","volume":"15","author":"L Stamatatos","year":"2009","journal-title":"Nat Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.virol.2008.12.032","article-title":"Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C human immunodeficiency virus type 1 env clones from India.","volume":"385","author":"SS Kulkarni","year":"2009","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/JVI.00257-07","article-title":"Unique mutational patterns in the envelope \u03b12 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralizaton of subtype C human immunodeficiency virus type 1.","volume":"81","author":"R Rong","year":"2007","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1131528","article-title":"Founder effects in the assessment of HIV polymorphisms and HLA allele associations.","volume":"315","author":"T Bhattacharya","year":"2007","journal-title":"Science"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1371\/journal.pone.0000591","article-title":"Leveraging hierarchical population structure in descrete association studies.","volume":"7","author":"J Carlson","year":"2007","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.","volume":"105","author":"BF Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref57","article-title":"Emergence of b12 resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.","author":"EM Bunnik","year":"2010","journal-title":"J Gen Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.01142-09","article-title":"Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody b12 that effectively targets the site of CD4 attachment.","volume":"83","author":"X Wu","year":"2009","journal-title":"J Virol"},{"key":"ref59","first-page":"696","article-title":"Syst Biol","volume":"52","author":"S Guindon","year":"2003","journal-title":"Syst Biol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core.","volume":"310","author":"C-C Huang","year":"2005","journal-title":"Science"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV-1 gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.","volume":"393","author":"PD Kwong","year":"1998","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/31514","article-title":"The antigenic structure of the HIV gp120 envelope glycoprotein.","volume":"393","author":"R Wyatt","year":"1998","journal-title":"Nature"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1128\/JVI.71.9.6869-6874.1997","article-title":"Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12.","volume":"71","author":"H Mo","year":"1997","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/JVI.77.1.642-658.2003","article-title":"Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.","volume":"77","author":"R Pantophlet","year":"2003","journal-title":"J Virol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome.","volume":"98","author":"NA Baker","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1073\/pnas.0807335105","article-title":"Potent HIV fusion inhibitors against enfuvirtide-resistant HIV-1 strains.","volume":"105","author":"Y He","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1074\/jbc.M609148200","article-title":"HIV gp41 C-terminal heptad repeat contains multifunctional domains.","volume":"282","author":"J Liu","year":"2007","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1128\/JVI.67.11.6897-6902.1993","article-title":"Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.","volume":"67","author":"NKT Back","year":"1993","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pmed.0050009","article-title":"Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.","volume":"5","author":"CA Blish","year":"2008","journal-title":"PLoS Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1128\/JVI.79.8.4774-4781.2005","article-title":"Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altrered receptor activation of gp120.","volume":"79","author":"E Desmezieres","year":"2005","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/viro.1993.1484","article-title":"An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(\u2192Thr) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.","volume":"196","author":"PJ Klasse","year":"1993","journal-title":"Virology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/JVI.74.9.4183-4191.2000","article-title":"A global neutralization resistant phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational changes of the envelope complex.","volume":"74","author":"EJ Park","year":"2000","journal-title":"J Virol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.72.9.7099-7107.1998","article-title":"Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.","volume":"72","author":"EJ Park","year":"1998","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0092-8674(88)90179-1","article-title":"Generation of a neutralization resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.","volume":"54","author":"MS Reitz","year":"1988","journal-title":"Cell"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/JVI.68.2.674-680.1994","article-title":"Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.","volume":"68","author":"M Thali","year":"1994","journal-title":"J Virol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.70.12.8431-8437.1996","article-title":"Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.","volume":"70","author":"BA Watkins","year":"1996","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1128\/JVI.00688-09","article-title":"Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies.","volume":"83","author":"SM O'Rourke","year":"2009","journal-title":"J Virol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/JVI.67.5.2747-2755.1993","article-title":"Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.","volume":"67","author":"J Cao","year":"1993","journal-title":"J Virol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/JVI.65.4.2119-2123.1991","article-title":"Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein.","volume":"65","author":"E Helseth","year":"1991","journal-title":"J Virol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/JVI.65.5.2682-2685.1991","article-title":"The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.","volume":"65","author":"M Ivey-Hoyle","year":"1991","journal-title":"J Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"27284","DOI":"10.1074\/jbc.M414411200","article-title":"Alanine scanning mutants of the HIV gp41 loop.","volume":"280","author":"A Jacobs","year":"2005","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JVI.77.1.560-570.2003","article-title":"Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.","volume":"77","author":"M Leavitt","year":"2003","journal-title":"J Virol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"42149","DOI":"10.1074\/jbc.M305223200","article-title":"Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.","volume":"278","author":"P Poumbourios","year":"2003","journal-title":"J Biol Chem"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"32644","DOI":"10.1074\/jbc.M806099200","article-title":"Role of the HIV gp120 conserved domain 1 in processing and viral entry.","volume":"283","author":"J Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/JVI.64.7.3240-3248.1990","article-title":"The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.","volume":"64","author":"C Wilson","year":"1990","journal-title":"J Virol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20042510","article-title":"Antigenic conservation and immunogenicity of the HIV coreceptor binding site.","volume":"201","author":"JM Decker","year":"2005","journal-title":"J Exp Med"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1128\/JVI.00758-09","article-title":"Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.","volume":"83","author":"ES Gray","year":"2009","journal-title":"J Virol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1128\/JVI.01359-09","article-title":"Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region.","volume":"83","author":"ES Gray","year":"2009","journal-title":"J Virol"},{"key":"ref89","first-page":"339","article-title":"Virology","volume":"396","author":"A Nandi","year":"2010","journal-title":"Virology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.","volume":"303","author":"CA Derdeyn","year":"2004","journal-title":"Science"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1128\/JVI.00201-06","article-title":"Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1.","volume":"80","author":"B Li","year":"2006","journal-title":"J Virol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"9586","DOI":"10.1128\/JVI.00141-06","article-title":"Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection and these modifications affect antibody neutralization sensitivity.","volume":"80","author":"M Sagar","year":"2006","journal-title":"J Virol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape.","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/JVI.76.8.3852-3864.2002","article-title":"Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.","volume":"76","author":"NG Hoffman","year":"2002","journal-title":"J Virol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JVI.01992-08","article-title":"Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.","volume":"83","author":"Y Li","year":"2009","journal-title":"J Virol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/088922200308747","article-title":"Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.","volume":"16","author":"C Rizzuto","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.","volume":"280","author":"CD Rizzuto","year":"1998","journal-title":"Science"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0042-6822(03)00521-X","article-title":"Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains.","volume":"315","author":"S-H Xiang","year":"2003","journal-title":"Virology"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/08892220260387959","article-title":"Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.","volume":"18","author":"S-H Xiang","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/JVI.80.2.750-758.2006","article-title":"Human immunodeficiency virus type 1 coreceptor switching: V1\/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.","volume":"80","author":"C Pastore","year":"2006","journal-title":"J Virol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.1175868","article-title":"Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.","volume":"326","author":"L Chen","year":"2009","journal-title":"Science"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03327","article-title":"Structure of an unliganded simian immunodeficiency virus gp120 core.","volume":"433","author":"B Chen","year":"2005","journal-title":"Nature"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/JVI.74.1.326-333.2000","article-title":"Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and revelas blocking activities of antibodies against cryptic conserved epitopes on gp120.","volume":"74","author":"K Salzwedel","year":"2000","journal-title":"J Virol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/JVI.67.7.3978-3988.1993","article-title":"Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.","volume":"67","author":"M Thali","year":"1993","journal-title":"J Virol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1128\/JVI.75.5.2041-2050.2001","article-title":"Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.","volume":"75","author":"P Kolchinsky","year":"2001","journal-title":"J Virol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/JVI.76.2.644-655.2002","article-title":"A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.","volume":"76","author":"PF Zhang","year":"2002","journal-title":"J Virol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1128\/JVI.77.19.10557-10565.2003","article-title":"Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.","volume":"77","author":"AF Labrijn","year":"2003","journal-title":"J Virol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"17477","DOI":"10.1073\/pnas.0707399104","article-title":"Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.","volume":"104","author":"A DeVico","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.3629244","article-title":"Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.","volume":"237","author":"M Kowalski","year":"1987","journal-title":"Science"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/JVI.64.12.5701-5707.1990","article-title":"Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.","volume":"64","author":"U Olshevsky","year":"1990","journal-title":"J Virol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.","volume":"79","author":"M Li","year":"2005","journal-title":"J Virol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa.","volume":"80","author":"M Li","year":"2006","journal-title":"J Virol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/QAD.0b013e32805e8727","article-title":"HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.","volume":"21","author":"CA Blish","year":"2007","journal-title":"AIDS"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JVI.02132-08","article-title":"Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.","volume":"83","author":"J Abrahams","year":"2009","journal-title":"J Virol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessments of neutralizing antibodies.","volume":"84","author":"MS Seaman","year":"2010","journal-title":"J Virol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JVI.02660-07","article-title":"Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","journal-title":"J Virol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.","volume":"43","author":"S Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.","volume":"73","author":"KS Lole","year":"1999","journal-title":"J Virol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.","volume":"84","author":"NA Doria-Rose","year":"2010","journal-title":"J Virol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/bioinformatics\/17.5.415","article-title":"Retrieval and on-th-fly alignment of sequence fragments from the HIV database.","volume":"17","author":"B Gaschen","year":"2001","journal-title":"Bioinformatics"},{"key":"ref121","first-page":"41","article-title":"fastDNAml: A tool for construction of phylogenetic trees of DNA sequences using maximum likelihood. Comput.","volume":"10","author":"GJ Olsen","year":"1994","journal-title":"Appl Biosci"},{"key":"ref122","first-page":"118","article-title":"In \u201cModern Developments in Theoretical Population Genetics: The legacy of Gustave Malecot.\u201d","author":"J Felsenstein","year":"2002"},{"key":"ref123","author":"TM Cover","year":"1991"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies.","volume":"100","author":"JD Storey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref125","article-title":"Classification and Regression Trees","author":"L Breiman","year":"1984"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1007515423169","article-title":"An empirical comparison of voting classification algorithms: Bagging, boosting, and variants.","volume":"36","author":"E Bauer","year":"1999","journal-title":"Mach Learn"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0969-2126(00)00547-5","article-title":"Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.","volume":"8","author":"PD Kwong","year":"2000","journal-title":"Structure Fold Des"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JVI.80.2.999-1014.2006","article-title":"Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian\/human immunodeficiency virus-infected macaques.","volume":"80","author":"WM Blay","year":"2006","journal-title":"J Virol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1093\/emboj\/17.16.4572","article-title":"Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.","volume":"17","author":"M Caffrey","year":"1998","journal-title":"EMBO J"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD\u2014Visual Molecular Dynamics.","volume":"14","author":"W Humphrey","year":"1996","journal-title":"J Mol Graphics"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:51:16Z","timestamp":1591966276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000955"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Fraser","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2010,10,7]]},"references-count":130,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000955","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6356957.6456055","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,7]]}}}